Shengxue Luo
Overview
Explore the profile of Shengxue Luo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
53
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Luo S, Zhang P, Wang Y, Huang Y, Ma X, Deng Q, et al.
Biomed Pharmacother
. 2023 Dec;
170:115901.
PMID: 38056238
Background: Hepatitis C virus (HCV) vaccines are an urgent need to prevent hepatitis C and its further progression of hepatocellular carcinoma. Since the promising T cell based chimpanzee adenovirus and...
2.
Zou P, Wang Q, Zhang P, Luo S, Wang C, Zhang E, et al.
Viral Immunol
. 2023 Oct;
36(9):617-625.
PMID: 37903228
Recombinant adenovirus vector has been widely used in vaccine development. Due to the pre-existing immunity of human adenovirus type 5 (HAd5) in humans, a range of rare human and chimpanzee...
3.
Zhang P, Luo S, Zou P, Deng Q, Wang C, Li J, et al.
Microbiol Spectr
. 2023 Oct;
11(6):e0179423.
PMID: 37877750
The essential goal of vaccination is to generate potent and long-term protection against diseases. Several factors including vaccine vector, delivery route, and boosting regimen influence the outcome of prime-boost immunization...
4.
Zou P, Zhang P, Deng Q, Wang C, Luo S, Zhang L, et al.
Microbiol Spectr
. 2023 Jun;
11(4):e0088023.
PMID: 37347197
Recombinant adenovirus vectors have been widely used in vaccine development. To overcome the preexisting immunity of human adenovirus type 5 (Ad5) in populations, a range of chimpanzee or rare human...
5.
Liu B, Zhang E, Ma X, Luo S, Wang C, Zhang L, et al.
Viruses
. 2023 May;
15(5).
PMID: 37243168
The major mechanism for determination of HCV infection outcomes has not been fully described, particularly in the early phase of the "window-period" of infection. Based on two groups of marmosets...
6.
Tang X, Yang L, Zhang P, Wang C, Luo S, Liu B, et al.
J Infect Dis
. 2023 May;
228(10):1375-1384.
PMID: 37170968
Background: The impact of hepatitis B surface antigen (HBsAg)-negative/hepatitis B virus (HBV) DNA-positive occult HBV infection (OBI) on the severity of liver fibrosis remains unclear. Methods: A total of 1772...
7.
Zhang P, Luo S, Zou P, Liang C, Wang C, Li J, et al.
Mol Ther Methods Clin Dev
. 2022 Jun;
26:181-190.
PMID: 35756078
Cats are susceptible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and risk transmitting viruses to naive cats or humans. Here, based on our novel adenovirus-vectored COVID-19 vaccine, the...
8.
Zhang W, Luo S, Li T, Wang M, Huang J, Liao Q, et al.
Front Microbiol
. 2022 Apr;
13:850665.
PMID: 35464946
There is little known of immunologic factors leading to the occurrence of occult HBV infection (OBI). Specific cellular immune response to hepatitis B virus (HBV) core/pol peptides was compared between...
9.
Luo S, Zhang P, Zou P, Wang C, Liu B, Wu C, et al.
Virol Sin
. 2021 Sep;
36(5):1113-1123.
PMID: 34581961
SARS-CoV-2 has caused more than 3.8 million deaths worldwide, and several types of COVID-19 vaccines are urgently approved for use, including adenovirus vectored vaccines. However, the thermal instability and pre-existing...
10.
Luo S, Zhang P, Liu B, Yang C, Liang C, Wang Q, et al.
Emerg Microbes Infect
. 2021 May;
10(1):1002-1015.
PMID: 33993845
COVID-19 vaccines are being developed urgently worldwide. Here, we constructed two adenovirus vectored COVID-19 vaccine candidates of Sad23L-nCoV-S and Ad49L-nCoV-S carrying the full-length gene of SARS-CoV-2 spike protein. The immunogenicity...